Analyst Ratings for Jasper Therapeutics (JSPR)
JSPR Rating Summary
JSPR Price Target Summary
- Highest: $20.00 (H.C. Wainwright)
- Lowest: $1.50 (UBS)
- Average: $8.07
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$8.07 (+1053.1%)
* Over Last 12-Mos
Rating Score: 6.3 / 10
Percentile Rank: 66%
Avg. $ Target:
$8.07 (+1053.1%)
* Over Last 12-Mos
Rating Score: 6.3 / 10
Percentile Rank: 66%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/12/2026 | Piper Sandler | Biren Amin | New Coverage | Overweight (N/A) |
2.00 (N/A) |
0.80 (0.70) |
-12.5% | Details |
| 5/15/2026 | TD Cowen | Yaron Werber | Downgrade | Hold (Buy) |
N/A (N/A) |
0.96 (0.70) |
-27.08% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
